Luca Tagliaferri

56PUBLICATIONS
165CO-AUTHORS
Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersOral and maxillofacial surgeryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Sep 26, 2026
Hypoxia-Targeting Strategies in Radiotherapy and Nitroimidazole-Based Radiosensitizers: A Narrative Review and Translational Perspectives.

|Aug 27, 2026
Revisiting the Abscopal Effect in the Era of Immuno-Radiotherapy: Mechanisms, Challenges, and Clinical Perspectives.

|Aug 13, 2026
A Narrative Review of da Vinci Single-Port Versus Multi-Port Robotic Surgery in Elderly or Frail Urological Cancer Patients.

|Jul 02, 2026
Survival outcomes after orbital exenteration for recurrent or previously treated orbital malignancies: impact of margin status and metastatic spread.

|Jun 27, 2026
p16(INK4a) immunohistochemical expression is a strong predictor of treatment response and survival in patients with locally advanced squamous cell vulvar cancer undergoing upfront chemoradiotherapy.

|Jan 06, 2026
Interventional Radiotherapy (Brachytherapy) for the Treatment of the Primary Lesion in Squamous Cell Carcinomas of the Oral Vestibule.

Andrea Tondo, Antonella Loperfido, Alessia Re

Pageof 10

Frequent Collaborators

19 joint publications

Bruno Fionda

12 joint publications

Valentina Lancellotta

9 joint publications

Francesco Bussu

7 joint publications

Gabriella Macchia